Net Asset Value(s)
Summary by AI BETAClose X
On 06-Nov-2026 Invesco NASDAQ Biotech UCITS ETF (ticker SBIO) reported a net asset value per share of USD 75.5253 with 7,966,396 shares in issue, implying total net assets of approximately USD 601.66 million; the announcement provides routine NAV information and contains no management guidance or operational changes likely to alter valuation drivers.
IVZ Nasdaq Biotech UCITS ETF$
09 November 2026
|
FUND: |
Invesco NASDAQ Biotech UCITS ETF |
|
DEALING DATE: |
06-Nov-26 |
|
NAV PER SHARE: |
USD:75.5253 |
|
NUMBER OF SHARES IN ISSUE: |
7,966,396.00 |
|
CODE: |
SBIO |
|
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 hour ago Oxford Nanopore Technologies
- 2 hours ago AVI Global Trust
- 2 hours ago LSL Property Services
- 2 hours ago Bluebird Merchant Ventures (DI)
- 2 hours ago Power Probe PLC